Breast cancer proliferative activity: Is it the source of serum free DNA?

被引：2
|
作者：
Hewala, Taha I. [1 ]
El-Moneim, Nadia A. Abd [2 ]
机构：
[1] Alexandria Univ, Med Res Inst, Dept Radiat Sci, 165 Horria Ave,El Hadara, Alexandria 21561, Egypt
[2] Alexandria Univ, Med Res Inst, Dept Canc Management & Res, Alexandria 21561, Egypt
来源：
ALEXANDRIA JOURNAL OF MEDICINE | 2013年 / 49卷 / 04期
关键词：
Breast cancer; Proliferative activity; Diagnosis; Prognosis; DNA; TPS; CEA;
D O I：
10.1016/j.ajme.2013.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: To study the relationship between serum DNA and breast cancer proliferative activity, then compare the diagnostic and prognostic values of serum DNA, TPS and CEA. Subjects and methods: A total of 100 breast cancer patients before surgery and 50 apparently healthy controls were analyzed for serum DNA, TPS and CEA. Results: Serum DNA levels were nonsignificantly correlated with serum TPS levels. Serum DNA, TPS and CEA levels were significantly higher in patients than controls. Using ROC curve analysis, serum TPS and DNA had the highest AUC compared to serum CEA. Neither serum TPS, DNA nor CEA correlated with breast cancer clinicopathological data. Only serum CEA was significantly correlated with patients' disease-free survival. Conclusion: Neither Breast cancer mass nor proliferative activity is the source of serum free DNA. Serum TPS is superior to DNA and CEA as a diagnostic marker for breast cancer. Only preoperative serum CEA has a prognostic role in predicting relapse of breast cancer patients, but not serum TPS or DNA. (C) 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.
引用
收藏
页码：337 / 341
页数：5
相关论文
共 50 条
  • [41] Diagnosis of breast cancer with infrared spectroscopy from serum samples
    Backhaus, Juergen
    Mueller, Ralf
    Formanski, Natalia
    Szlama, Nicole
    Meerpohl, Hans-Gerd
    Eidt, Manfred
    Bugert, Peter
    VIBRATIONAL SPECTROSCOPY, 2010, 52 (02) : 173 - 177
  • [42] Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods
    Li, Lu
    Gao, Qilong
    Xu, Guolin
    Shi, Bian
    Ma, Xuhui
    Liu, Huaimin
    Li, Qiujian
    Tian, Tongde
    Tang, Jingwen
    Niu, Hong
    CANCER BIOMARKERS, 2017, 19 (04) : 403 - 409
  • [43] Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
    Shan, Ming
    Yin, Huizi
    Li, Junnan
    Li, Xiaobo
    Wang, Dong
    Su, Yonghui
    Niu, Ming
    Zhong, Zhenbin
    Wang, Ji
    Zhang, Xianyu
    Kang, Wenli
    Pang, Da
    ONCOTARGET, 2016, 7 (14) : 18485 - 18494
  • [44] Serum cotinine and prognosis in breast cancer
    Johnson, L.
    Agbaje, O.
    Doig, M.
    Fentiman, I. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 811 - 814
  • [45] Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
    Imamura, Michiko
    Morimoto, Takashi
    Nomura, Takashi
    Michishita, Shintaro
    Nishimukai, Arisa
    Higuchi, Tomoko
    Fujimoto, Yukie
    Miyagawa, Yoshimasa
    Kira, Ayako
    Murase, Keiko
    Araki, Kazuhiro
    Takatsuka, Yuichi
    Oh, Koshi
    Masai, Yoshikazu
    Akazawa, Kouhei
    Miyoshi, Yasuo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [46] Elevated Serum Arginase Activity Levels in Patients with Breast Cancer
    Muhammet Fevzİ Polat
    Seyİthan Taysİ
    SevİnÇ Polat
    Abdullah BÖyÜk
    Ebubekİr Bakan
    Surgery Today, 2003, 33 : 655 - 661
  • [47] Elevated serum arginase activity levels in patients with breast cancer
    Polat, MF
    Taysi, S
    Polat, S
    Böyük, A
    Bakan, E
    SURGERY TODAY, 2003, 33 (09) : 655 - 661
  • [48] Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis
    Oyama, T
    Takei, H
    Hikino, T
    Iino, Y
    Nakajima, T
    ONCOLOGY, 1996, 53 (02) : 112 - 117
  • [49] Serum cotinine and prognosis in breast cancer
    L. Johnson
    O. Agbaje
    M. Doig
    I. S. Fentiman
    Breast Cancer Research and Treatment, 2012, 134 : 811 - 814
  • [50] Serum Chemerin Level in Breast Cancer
    Akin, Serkan
    Akin, Safak
    Gedik, Emre
    Haznedaroglu, Elif
    Dogan, Ayse L.
    Altundag, Mustafa K.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2017, 27 (02): : 127 - 132
12345